2014
DOI: 10.1016/j.neuropharm.2013.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress

Abstract: Parkinson's disease (PD) shows a complex etiology, where both genetic and environmental factors contribute to initiation and advance of pathology. Mitochondrial dysfunction and mutation of genes implicated in mitochondria quality control are recognized contributors to etiopathology and progression of PD. Here we report the development and characterization of a genetic mouse model of PD with a combined etiology comprising: 1) induction of mitochondrial stress achieved through the expression of a mitochondrial m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
41
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(45 citation statements)
references
References 39 publications
4
41
0
Order By: Relevance
“…Therefore, as in cardiac tissue, the mitochondrial quality control function of the PINK1/Parkin pathway may become essential in the central nervous system under stress conditions, for example following accumulation of oxidative stress during ageing [63]. Consistent with this possibility, mitochondrial stress caused by the conditional expression of mitochondrial unfolded ornithine transcarbamylase has been recently shown to lead to dopaminergic neurodegeneration and a parkinsonian phenotype in PINK1−/− mice [64].…”
Section: Discussionmentioning
confidence: 93%
“…Therefore, as in cardiac tissue, the mitochondrial quality control function of the PINK1/Parkin pathway may become essential in the central nervous system under stress conditions, for example following accumulation of oxidative stress during ageing [63]. Consistent with this possibility, mitochondrial stress caused by the conditional expression of mitochondrial unfolded ornithine transcarbamylase has been recently shown to lead to dopaminergic neurodegeneration and a parkinsonian phenotype in PINK1−/− mice [64].…”
Section: Discussionmentioning
confidence: 93%
“…We found no differences between the Hp1bp3 KO and WT mice on these measures, suggesting that the effects of Hp1bp3 KO reported herein are not due to gross behavioral abnormalities. Other positional candidates identified in the CFM QTL, such as Pink1 and Kif17 (Table 1), have been linked to cognitive deficits (Roberson, et al, 2008) and neurodegeneration (Moisoi, et al, 2014) and contain variants that could impact gene function or expression. Here, we focused on genetic correlates of CFM expressed in the hippocampus due to the hippocampal-dependent nature of contextual fear conditioning (Chen, et al, 1996) and the fact that the hippocampus is one of the first structures affected in aging (Burke and Barnes, 2006; Gant, et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Pimenta de Castro and colleagues have speculated that AMPK-dependent autophagy may exert a protective role in this fly model of protein misfolding (2012). Notably, shortly after the Drosophila model of dOTC was published, researchers published a mouse model of PD where dOTC expression is driven by the tyrosine hydroxylase promoter (Moisoi et al 2014). This progression from early experiments in flies to ensuing studies in mice underscores the translational merit of Drosophila research.…”
Section: 2 Selected Disease Models Studied In Drosophilamentioning
confidence: 99%